JP2012533630A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012533630A5 JP2012533630A5 JP2012521700A JP2012521700A JP2012533630A5 JP 2012533630 A5 JP2012533630 A5 JP 2012533630A5 JP 2012521700 A JP2012521700 A JP 2012521700A JP 2012521700 A JP2012521700 A JP 2012521700A JP 2012533630 A5 JP2012533630 A5 JP 2012533630A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- substituted
- acceptable salt
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HZXBVTUZHCBOSI-UHFFFAOYSA-N C(COC1)C1OC1CCCCC1 Chemical compound C(COC1)C1OC1CCCCC1 HZXBVTUZHCBOSI-UHFFFAOYSA-N 0.000 description 2
- 0 C[C@](CC1)CC[C@]1C(*c1c(C(O)=O)[s]c(C#CC(C)(C)COC2CCOCC2)c1)=O Chemical compound C[C@](CC1)CC[C@]1C(*c1c(C(O)=O)[s]c(C#CC(C)(C)COC2CCOCC2)c1)=O 0.000 description 2
- STYZOEAXSMEXGV-PDPKZZNXSA-N CC(CC1)CCC1C(N(CCOc1ncccc1)c1c(C(O)=O)[s]c(C#CC(C)(C)Cc2nc(S[C@H](CC3)CC[C@@H]3N(C([C@H]3CC[C@H](C)CC3)=O)c3c(C(O)=O)[s]c(C#CC(C)(C)C)c3)ncc2)c1)=O Chemical compound CC(CC1)CCC1C(N(CCOc1ncccc1)c1c(C(O)=O)[s]c(C#CC(C)(C)Cc2nc(S[C@H](CC3)CC[C@@H]3N(C([C@H]3CC[C@H](C)CC3)=O)c3c(C(O)=O)[s]c(C#CC(C)(C)C)c3)ncc2)c1)=O STYZOEAXSMEXGV-PDPKZZNXSA-N 0.000 description 1
- KFVRDWIDIHRPMV-RZZSZECMSA-N CC(CC1)CCC1C(N([C@H](CC1)CC[C@@H]1Oc1nccc(C(NC2CCN(C)CC2)=O)c1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound CC(CC1)CCC1C(N([C@H](CC1)CC[C@@H]1Oc1nccc(C(NC2CCN(C)CC2)=O)c1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O KFVRDWIDIHRPMV-RZZSZECMSA-N 0.000 description 1
- HQJJNPLFWPONOJ-AULMGXOSSA-N CC(CC1)CCC1C(N([C@H](CC1)CC[C@H]1Oc1cc(CN(C)C)ccn1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound CC(CC1)CCC1C(N([C@H](CC1)CC[C@H]1Oc1cc(CN(C)C)ccn1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O HQJJNPLFWPONOJ-AULMGXOSSA-N 0.000 description 1
- QOMDMGYFGNODAG-NHIIVYHSSA-N CCc(cn1)cnc1O[C@H](CC1)CC[C@@H]1N(C([C@H]1CC[C@H](C)CC1)=O)c1c(C(O)=O)[s]c(C#CC(C)(C)Cc2nc(O[C@H](CC3)CC[C@H]3N(C([C@H]3CC[C@H](C)CC3)=O)c3c(C(O)=O)[s]c(C#CC(C)(C)C)c3)ncc2)c1 Chemical compound CCc(cn1)cnc1O[C@H](CC1)CC[C@@H]1N(C([C@H]1CC[C@H](C)CC1)=O)c1c(C(O)=O)[s]c(C#CC(C)(C)Cc2nc(O[C@H](CC3)CC[C@H]3N(C([C@H]3CC[C@H](C)CC3)=O)c3c(C(O)=O)[s]c(C#CC(C)(C)C)c3)ncc2)c1 QOMDMGYFGNODAG-NHIIVYHSSA-N 0.000 description 1
- FOEMIZSFFWGXHX-UHFFFAOYSA-N CSc1ncccn1 Chemical compound CSc1ncccn1 FOEMIZSFFWGXHX-UHFFFAOYSA-N 0.000 description 1
- DCVXXBSOALSOCT-ACRUOGEOSA-N C[C@@H](CCOc1cnccc1)N(C([C@H]1CC[C@H](C)CC1)=O)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1 Chemical compound C[C@@H](CCOc1cnccc1)N(C([C@H]1CC[C@H](C)CC1)=O)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1 DCVXXBSOALSOCT-ACRUOGEOSA-N 0.000 description 1
- JIMBKAVWHTWXQJ-UFYCRDLUSA-N C[C@@H](CCOc1ncccn1)N(C([C@H]1CC[C@H](C)CC1)=O)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1 Chemical compound C[C@@H](CCOc1ncccn1)N(C([C@H]1CC[C@H](C)CC1)=O)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1 JIMBKAVWHTWXQJ-UFYCRDLUSA-N 0.000 description 1
- CKHSTWDUMMKPEL-MEMLXQNLSA-N C[C@H](CC1)CC[C@@H]1C(N(C(CC1)CCN1S(c1cnccc1)(=O)=O)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N(C(CC1)CCN1S(c1cnccc1)(=O)=O)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O CKHSTWDUMMKPEL-MEMLXQNLSA-N 0.000 description 1
- ROHZXBGOWBVRHI-ACRUOGEOSA-N C[C@H](CC1)CC[C@@H]1C(N([C@@H](CC1)CN1S(c1cnccc1)(=O)=O)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@@H](CC1)CN1S(c1cnccc1)(=O)=O)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O ROHZXBGOWBVRHI-ACRUOGEOSA-N 0.000 description 1
- LVAVEGHVIHKCNJ-IFSQOONMSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1OC(C=CN1)=NC1=O)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1OC(C=CN1)=NC1=O)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O LVAVEGHVIHKCNJ-IFSQOONMSA-N 0.000 description 1
- COACHVJQVZURCG-IFSQOONMSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc(nn1)ccc1O)c1c(C(O)=O)[s]c(C#CC2(CCC2)C(F)(F)F)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc(nn1)ccc1O)c1c(C(O)=O)[s]c(C#CC2(CCC2)C(F)(F)F)c1)=O COACHVJQVZURCG-IFSQOONMSA-N 0.000 description 1
- HUEMGDNXEQTFAN-PBCKQTSCSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1c(CN(CC2)CC2N(C)C)ccnc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1c(CN(CC2)CC2N(C)C)ccnc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O HUEMGDNXEQTFAN-PBCKQTSCSA-N 0.000 description 1
- CDPLEDLRPNRMEH-QWZLJSJVSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1cc(CN(C)C)ccn1)c1c(C(O)=O)[s]c(C#CC2(CC2)C(F)(F)F)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1cc(CN(C)C)ccn1)c1c(C(O)=O)[s]c(C#CC2(CC2)C(F)(F)F)c1)=O CDPLEDLRPNRMEH-QWZLJSJVSA-N 0.000 description 1
- KVOUESFXZQCLLP-MVBYDDMTSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1cc(CN(C)C)cnc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1cc(CN(C)C)cnc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O KVOUESFXZQCLLP-MVBYDDMTSA-N 0.000 description 1
- DWVPQAZEQIOEDS-MUGGOUMZSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1nc(CN2CCOCC2)ccc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1nc(CN2CCOCC2)ccc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O DWVPQAZEQIOEDS-MUGGOUMZSA-N 0.000 description 1
- UUCQLJNFHZYTON-MVBYDDMTSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1nccc(CN(C)C)c1)c1c(C(O)=O)[s]c(C#CC2(CCC2)C(F)(F)F)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1nccc(CN(C)C)c1)c1c(C(O)=O)[s]c(C#CC2(CCC2)C(F)(F)F)c1)=O UUCQLJNFHZYTON-MVBYDDMTSA-N 0.000 description 1
- SXKJFTGLURDMII-CHDDOINTSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1ncncc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Oc1ncncc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O SXKJFTGLURDMII-CHDDOINTSA-N 0.000 description 1
- HWFPVIWQOUDLIC-REODPECZSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1S/C(/NN)=C/N)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1S/C(/NN)=C/N)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O HWFPVIWQOUDLIC-REODPECZSA-N 0.000 description 1
- ZGGSKCQZMYXDOB-UBBSCCEASA-O C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Sc1[nH+][nH]cn1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Sc1[nH+][nH]cn1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O ZGGSKCQZMYXDOB-UBBSCCEASA-O 0.000 description 1
- OYMKPOCENOJCMQ-KBQPQWKXSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Sc1ccccn1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Sc1ccccn1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O OYMKPOCENOJCMQ-KBQPQWKXSA-N 0.000 description 1
- JCGVRQXBRNGKFH-YSXIEMCBSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Sc1nnc(C)[o]1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@@H]1Sc1nnc(C)[o]1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O JCGVRQXBRNGKFH-YSXIEMCBSA-N 0.000 description 1
- GSRQLELLPZXJEL-AGJYPBCPSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@H]1Oc1cccnc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@H]1Oc1cccnc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O GSRQLELLPZXJEL-AGJYPBCPSA-N 0.000 description 1
- HUDMIVJEYSDLFN-SVRSMAFJSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@H]1Oc1cncnc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@H]1Oc1cncnc1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O HUDMIVJEYSDLFN-SVRSMAFJSA-N 0.000 description 1
- HSSVKHZTWZIETE-PVPVSOICSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@H]1Sc1ncc[s]1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CC1)CC[C@H]1Sc1ncc[s]1)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O HSSVKHZTWZIETE-PVPVSOICSA-N 0.000 description 1
- HYGZCHJAYASXHA-YDHSSHFGSA-N C[C@H](CC1)CC[C@@H]1C(N([C@H](CCOc1ccccn1)OC1=O)c2c1[s]c(C#CC(C)(C)C)c2)=O Chemical compound C[C@H](CC1)CC[C@@H]1C(N([C@H](CCOc1ccccn1)OC1=O)c2c1[s]c(C#CC(C)(C)C)c2)=O HYGZCHJAYASXHA-YDHSSHFGSA-N 0.000 description 1
- ICVBBGCKGONZJH-HDJSIYSDSA-N C[C@H](CC1)CC[C@@H]1[IH](N(C)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O Chemical compound C[C@H](CC1)CC[C@@H]1[IH](N(C)c1c(C(O)=O)[s]c(C#CC(C)(C)C)c1)=O ICVBBGCKGONZJH-HDJSIYSDSA-N 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22736709P | 2009-07-21 | 2009-07-21 | |
| US61/227,367 | 2009-07-21 | ||
| US24091109P | 2009-09-09 | 2009-09-09 | |
| US61/240,911 | 2009-09-09 | ||
| US35946610P | 2010-06-29 | 2010-06-29 | |
| US61/359,466 | 2010-06-29 | ||
| PCT/US2010/042394 WO2011011303A1 (en) | 2009-07-21 | 2010-07-19 | Inhibitors of flaviviridae viruses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015160807A Division JP2015205940A (ja) | 2009-07-21 | 2015-08-18 | フラビウイルス科ウイルスの阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012533630A JP2012533630A (ja) | 2012-12-27 |
| JP2012533630A5 true JP2012533630A5 (enExample) | 2015-02-26 |
| JP5841531B2 JP5841531B2 (ja) | 2016-01-13 |
Family
ID=42711860
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012521700A Expired - Fee Related JP5841531B2 (ja) | 2009-07-21 | 2010-07-19 | フラビウイルス科ウイルスの阻害剤 |
| JP2015160807A Withdrawn JP2015205940A (ja) | 2009-07-21 | 2015-08-18 | フラビウイルス科ウイルスの阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015160807A Withdrawn JP2015205940A (ja) | 2009-07-21 | 2015-08-18 | フラビウイルス科ウイルスの阻害剤 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US8569302B2 (enExample) |
| EP (1) | EP2475657B1 (enExample) |
| JP (2) | JP5841531B2 (enExample) |
| KR (1) | KR20120051022A (enExample) |
| CN (1) | CN102471327A (enExample) |
| AP (1) | AP3409A (enExample) |
| AR (1) | AR077765A1 (enExample) |
| AU (1) | AU2010276441B2 (enExample) |
| CA (1) | CA2767088C (enExample) |
| CL (1) | CL2012000147A1 (enExample) |
| CO (1) | CO6491049A2 (enExample) |
| CR (1) | CR20120081A (enExample) |
| DK (1) | DK2475657T3 (enExample) |
| EA (1) | EA020816B1 (enExample) |
| EC (1) | ECSP12011684A (enExample) |
| ES (1) | ES2427342T3 (enExample) |
| IL (1) | IL217243A (enExample) |
| MX (1) | MX2012000959A (enExample) |
| NZ (1) | NZ597528A (enExample) |
| PE (1) | PE20120666A1 (enExample) |
| SG (1) | SG177709A1 (enExample) |
| TW (1) | TW201116525A (enExample) |
| UY (1) | UY32793A (enExample) |
| WO (1) | WO2011011303A1 (enExample) |
| ZA (1) | ZA201200940B (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010276441B2 (en) * | 2009-07-21 | 2015-07-02 | Gilead Sciences, Inc. | Inhibitors of Flaviviridae viruses |
| EP2507249B1 (en) | 2009-09-09 | 2015-11-11 | Gilead Sciences, Inc. | Inhibitors of flaviviridae viruses |
| TWI483950B (zh) | 2009-09-21 | 2015-05-11 | Gilead Sciences Inc | 用於製備１’－取代碳核苷類似物之方法及中間物 |
| AU2011205744B2 (en) * | 2010-01-15 | 2015-06-25 | Gilead Sciences, Inc. | Inhibitors of Flaviviridae viruses |
| PT2523951E (pt) * | 2010-01-15 | 2015-09-14 | Gilead Sciences Inc | Inibidores de vírus flaviviridae |
| UY33473A (es) * | 2010-06-28 | 2012-01-31 | Vertex Pharma | Compuestos y métodos para el tratamiento o la prevencion de infecciones por flavivirus |
| PH12013500035A1 (en) | 2010-07-22 | 2013-03-11 | Gilead Sciences Inc | Methods and compounds for treating paramyxoviridae virus infections |
| WO2012010663A1 (en) | 2010-07-22 | 2012-01-26 | Novartis Ag | 2,3,5-trisubstituted thiophene compounds and uses thereof |
| EP2734515B1 (en) * | 2011-07-13 | 2015-11-04 | Gilead Sciences, Inc. | Thiophen-2-carboxylic acid derivatives useful as inhibitors of flaviviridae viruses |
| LT2864291T (lt) | 2012-06-26 | 2017-01-10 | Bayer Pharma Aktiengesellschaft | N-[4-(chinolin-4-iloksi)cikloheksil(metil)](hetero)arilkarboksamidai kaip androgeno receptoriaus antagonistai, jų gamyba ir panaudojimas kaip medicininių produktų |
| US8841340B2 (en) | 2012-08-17 | 2014-09-23 | Gilead Sciences, Inc. | Solid forms of an antiviral compound |
| US8759544B2 (en) | 2012-08-17 | 2014-06-24 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
| US8927741B2 (en) | 2012-08-17 | 2015-01-06 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
| CN102964295B (zh) * | 2012-12-17 | 2014-08-20 | 寿光富康制药有限公司 | 一种2-取代-4-（哌啶基甲基）吡啶的制备方法 |
| EP2762124A1 (en) * | 2013-01-31 | 2014-08-06 | IP Gesellschaft für Management mbH | Packaging comprising administration units of polymorphs, amorphous forms or solvates |
| US9492438B2 (en) * | 2014-07-25 | 2016-11-15 | Bette Pollard | Amphiphilic pyridinum compounds to treat epilepsy and other disorders of the nervous system |
| TWI740546B (zh) | 2014-10-29 | 2021-09-21 | 美商基利科學股份有限公司 | 製備核糖苷的方法 |
| SG10202105371YA (en) | 2014-12-26 | 2021-07-29 | Univ Emory | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| SG10202109869XA (en) | 2015-09-16 | 2021-10-28 | Gilead Sciences Inc | Methods for treating arenaviridae and coronaviridae virus infections |
| WO2017197051A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Amine-linked c3-glutarimide degronimers for target protein degradation |
| ES2989988T3 (es) | 2016-05-10 | 2024-11-28 | C4 Therapeutics Inc | Degronímeros heterorocíclicos para la degradación de proteínas diana |
| WO2017197046A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | C3-carbon linked glutarimide degronimers for target protein degradation |
| CN109562113A (zh) | 2016-05-10 | 2019-04-02 | C4医药公司 | 用于靶蛋白降解的螺环降解决定子体 |
| LT3464336T (lt) | 2016-06-01 | 2022-05-10 | Athira Pharma, Inc. | Junginiai |
| CN110869028B (zh) | 2017-03-14 | 2023-01-20 | 吉利德科学公司 | 治疗猫冠状病毒感染的方法 |
| ES2938859T3 (es) | 2017-05-01 | 2023-04-17 | Gilead Sciences Inc | Una forma cristalina de (S)-2-etilbutilo 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopirrolo[2,1-f][1,2,4]triazin-7-il)-5-ciano-3,4-dihidroxitetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato |
| CN110769822A (zh) | 2017-06-20 | 2020-02-07 | C4医药公司 | 用于蛋白降解的n/o-连接的降解决定子和降解决定子体 |
| WO2019014247A1 (en) | 2017-07-11 | 2019-01-17 | Gilead Sciences, Inc. | COMPOSITIONS COMPRISING POLYMERASE RNA INHIBITOR AND CYCLODEXTRIN FOR THE TREATMENT OF VIRAL INFECTIONS |
| FI3706762T3 (fi) | 2017-12-07 | 2024-12-13 | Univ Emory | N4-hydroksisytidiini ja johdannaisia sekä niihin liittyviä virusten vastaisia käyttötapoja |
| CN118662520A (zh) | 2020-01-27 | 2024-09-20 | 吉利德科学公司 | 用于治疗SARS CoV-2感染的方法 |
| US11613553B2 (en) | 2020-03-12 | 2023-03-28 | Gilead Sciences, Inc. | Methods of preparing 1′-cyano nucleosides |
| EP4132651B1 (en) | 2020-04-06 | 2026-03-18 | Gilead Sciences, Inc. | Inhalation formulations of 1'-cyano substituted carbanucleoside analogs |
| ES3041698T3 (en) | 2020-05-29 | 2025-11-13 | Gilead Sciences Inc | Remdesivir for the treatment of viral infections |
| EP4172160A2 (en) | 2020-06-24 | 2023-05-03 | Gilead Sciences, Inc. | 1'-cyano nucleoside analogs and uses thereof |
| US12577240B2 (en) | 2020-07-11 | 2026-03-17 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| HUE067491T2 (hu) | 2020-08-27 | 2024-10-28 | Gilead Sciences Inc | Vegyületek és eljárások vírusfertõzések kezelésére |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| AU2023227794A1 (en) | 2022-03-02 | 2024-10-17 | Gilead Sciences, Inc. | Compounds and methods for treatment of viral infections |
| US12357577B1 (en) | 2024-02-02 | 2025-07-15 | Gilead Sciences, Inc. | Pharmaceutical formulations and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861421A (en) | 1995-12-21 | 1999-01-19 | Smithkline Beecham Corporation | 4,4-(disubstituted) cyclohexan-1-one monomers and related compounds |
| US20020002199A1 (en) * | 1998-03-12 | 2002-01-03 | Lone Jeppesen | Modulators of protein tyrosine phosphatases (ptpases) |
| US20050119332A1 (en) * | 1998-03-12 | 2005-06-02 | Lone Jeppesen | Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
| US6887877B2 (en) * | 2001-06-11 | 2005-05-03 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of Flavivirus infections |
| CN101624391A (zh) * | 2001-06-11 | 2010-01-13 | 病毒化学医药公司 | 用作黄病毒感染抗病毒剂的噻吩衍生物 |
| CN100413861C (zh) * | 2002-12-10 | 2008-08-27 | 维勒凯姆制药股份有限公司 | 用于治疗或预防黄病毒感染的化合物 |
| EP1569929B9 (en) | 2002-12-10 | 2011-09-14 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| DE10359791A1 (de) * | 2003-12-19 | 2005-07-21 | Bayer Healthcare Ag | Substituierte Thiophene |
| WO2005081954A2 (en) * | 2004-02-25 | 2005-09-09 | Wyeth | Inhibitors of protein tyrosine phosphatase 1b |
| RU2006138036A (ru) * | 2004-03-30 | 2008-05-10 | Чирон Корпорейшн (Us) | Производные замещенного тиофена в качестве противораковых средств |
| DE102004061746A1 (de) * | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Alkinyl-substituierte Thiophene |
| DE102005028077A1 (de) | 2004-12-22 | 2006-07-13 | Aicuris Gmbh & Co. Kg | Alkinyl-substituierte Thiophene |
| US7569600B2 (en) * | 2005-05-13 | 2009-08-04 | Virochem Pharma Inc. | Compounds and methods for the treatment of prevention of Flavivirus infections |
| TW200801022A (en) * | 2006-02-15 | 2008-01-01 | Sanofi Aventis | Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| CN102675279A (zh) * | 2006-11-15 | 2012-09-19 | Viro化学制药公司 | 用于治疗或预防黄病毒属感染的噻吩类似物 |
| WO2008059042A1 (en) * | 2006-11-17 | 2008-05-22 | Smithkline Beecham Corporation | 2-carboxy thiophene derivatives as anti viral agents |
| BRPI0922364A2 (pt) | 2008-12-03 | 2017-08-29 | Presidio Pharmaceuticals Inc | Composto, composição farmacêutica e uso de um composto |
| AU2010276441B2 (en) * | 2009-07-21 | 2015-07-02 | Gilead Sciences, Inc. | Inhibitors of Flaviviridae viruses |
| EP2507249B1 (en) * | 2009-09-09 | 2015-11-11 | Gilead Sciences, Inc. | Inhibitors of flaviviridae viruses |
| MX2012006026A (es) | 2009-11-25 | 2012-08-15 | Vertex Pharma | Derivados de acido 5-alquinil-tiofen-2-carboxilico y usos para tratamiento o prevencion de infecciones por flavivirus. |
| AU2011205744B2 (en) | 2010-01-15 | 2015-06-25 | Gilead Sciences, Inc. | Inhibitors of Flaviviridae viruses |
| PT2523951E (pt) * | 2010-01-15 | 2015-09-14 | Gilead Sciences Inc | Inibidores de vírus flaviviridae |
| UY33473A (es) | 2010-06-28 | 2012-01-31 | Vertex Pharma | Compuestos y métodos para el tratamiento o la prevencion de infecciones por flavivirus |
-
2010
- 2010-07-19 AU AU2010276441A patent/AU2010276441B2/en not_active Ceased
- 2010-07-19 SG SG2012004115A patent/SG177709A1/en unknown
- 2010-07-19 AR ARP100102629A patent/AR077765A1/es unknown
- 2010-07-19 TW TW099123657A patent/TW201116525A/zh unknown
- 2010-07-19 ES ES10735402T patent/ES2427342T3/es active Active
- 2010-07-19 AP AP2012006085A patent/AP3409A/xx active
- 2010-07-19 CA CA2767088A patent/CA2767088C/en not_active Expired - Fee Related
- 2010-07-19 EP EP10735402.9A patent/EP2475657B1/en active Active
- 2010-07-19 JP JP2012521700A patent/JP5841531B2/ja not_active Expired - Fee Related
- 2010-07-19 NZ NZ597528A patent/NZ597528A/en not_active IP Right Cessation
- 2010-07-19 CN CN2010800328463A patent/CN102471327A/zh active Pending
- 2010-07-19 DK DK10735402.9T patent/DK2475657T3/da active
- 2010-07-19 KR KR1020127004379A patent/KR20120051022A/ko not_active Withdrawn
- 2010-07-19 MX MX2012000959A patent/MX2012000959A/es active IP Right Grant
- 2010-07-19 UY UY0001032793A patent/UY32793A/es not_active Application Discontinuation
- 2010-07-19 WO PCT/US2010/042394 patent/WO2011011303A1/en not_active Ceased
- 2010-07-19 PE PE2012000069A patent/PE20120666A1/es not_active Application Discontinuation
- 2010-07-19 US US12/838,684 patent/US8569302B2/en active Active
- 2010-07-19 EA EA201290053A patent/EA020816B1/ru not_active IP Right Cessation
-
2011
- 2011-12-28 IL IL217243A patent/IL217243A/en not_active IP Right Cessation
-
2012
- 2012-01-17 CO CO12006267A patent/CO6491049A2/es active IP Right Grant
- 2012-01-19 CL CL2012000147A patent/CL2012000147A1/es unknown
- 2012-02-08 ZA ZA2012/00940A patent/ZA201200940B/en unknown
- 2012-02-16 CR CR20120081A patent/CR20120081A/es unknown
- 2012-02-16 EC ECSP12011684 patent/ECSP12011684A/es unknown
-
2013
- 2013-09-25 US US14/037,296 patent/US20140030223A1/en not_active Abandoned
-
2015
- 2015-08-18 JP JP2015160807A patent/JP2015205940A/ja not_active Withdrawn